Clinical Trials Browser

Phase 3 × OTHER × Bronchiolitis Obliterans Syndrome × Clear all

NCT01460693 2018-04-24

SPIRIT2

Phase 3 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT01819389 2014-01-07

Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance

Phase 3 Completed

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive